Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/26/2010US20100216702 Vegf analogs and methods of use
08/26/2010US20100216701 Protein Kinase C Inhibitors for Prevention of Insulin Resistance and Type 2 Diabetes
08/26/2010US20100216700 Methods of treating ocular disorders
08/26/2010US20100216699 Semi-synthetic glycopeptides having antibacterial activity
08/26/2010US20100216698 Liquid formulations of g-csf
08/26/2010US20100216697 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
08/26/2010US20100216696 Compounds and methods for treating cancer
08/26/2010US20100216695 Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders
08/26/2010US20100216694 Antidiabetic tricyclic compounds
08/26/2010US20100216693 Compositions and methods of treating diabetes
08/26/2010US20100216692 Acidic Insulin Preparations Having Improved Stability
08/26/2010US20100216691 Protease Stabilized, Pegylated Insulin Analogues
08/26/2010US20100216690 Pegylated Single-Chain Insulin
08/26/2010US20100216689 Cytotoxic t cell activator comprising ep4 agonist
08/26/2010US20100216688 Peptidomimetic macrocycles
08/26/2010US20100216235 Dipeptidyl peptidases
08/26/2010US20100216140 Novel Human Dickkopf-Related Protein and Nucleic Acid Molecules and uses Therefor
08/26/2010US20100215779 Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
08/26/2010US20100215749 TEMPERATURE- AND pH-RESPONSIVE POLYMER COMPOSITIONS
08/26/2010US20100215734 Pharmaceutical compositions
08/26/2010US20100215732 Ingestible implement for weight control
08/26/2010US20100215731 Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
08/26/2010US20100215729 Oligonucleotide analogues incorporating 5-aza-cytosine therein
08/26/2010US20100215728 Skincare Methods
08/26/2010US20100215726 Compositions for Diminishing the Appearance of Wrinkles
08/26/2010US20100215724 Microcapsule Nanotube Devices for Targeted Delivery of Therapeutic Molecules
08/26/2010US20100215722 Tissue Regeneration II
08/26/2010US20100215718 Bone Graft Material Containment Structures
08/26/2010US20100215716 Compositions and methods for coating orthopedic implants
08/26/2010US20100215713 Scaffolds for follicle transplantation
08/26/2010US20100215711 Stabilized enzyme compositions
08/26/2010US20100215699 Lactoferrin as a radioprotective agent
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215689 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
08/26/2010US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215676 Kdr peptides and vaccines comprising the same
08/26/2010US20100215668 Methods for the treatment or prevention of hemorrhagic conditions
08/26/2010US20100215663 Methods and compositions for regulation of neurological conditions
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215660 Kruppel-like factors and fat regulation
08/26/2010US20100215655 Angiogenesis-inhibiting chimeric proteins and the use
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215645 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of any of SEQ ID NOS:10,916-49,582 and 50,231
08/26/2010US20100215644 Analysis of nodes in cellular pathways
08/26/2010US20100215640 Method for inhibiting cellular activation by insulin-like growth factor-1
08/26/2010US20100215638 Method for treatment of prostate cancer and screening of patients benefiting from said method
08/26/2010US20100215637 Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
08/26/2010US20100215636 Peptides derived from plasminogen activator inhibitor-1 and uses thereof
08/26/2010US20100215635 Small molecules to induce weight loss or to reduce weight gain
08/26/2010US20100215634 Visfatin therapeutic agents for the treatment of acne and other conditions
08/26/2010US20100215633 Method for feeding dairy cows and dairy goats supplements to increase the C2 hxroylated estrogen (C2) to C16 hydroxlated estrogen (C16) ratio secreted in their urine
08/26/2010US20100215632 Biomarkers of sirtuin activity and methods of use thereof
08/26/2010US20100215631 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
08/26/2010US20100215619 Hla peptide therapy
08/26/2010US20100215618 Novel compounds - 644
08/26/2010US20100215617 Enhanced medical implant
08/26/2010US20100215616 Hepatitis C Virus Inhibitors
08/26/2010US20100215615 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010US20100215591 Antimicrobial peptide, compositions, and methods of use
08/26/2010US20100215583 Cell nucleus-entering compositions
08/26/2010US20100215577 Compositions and methods for visualizing and eliminating cancer stem cells
08/26/2010US20100215576 Diagnosis and treatment of neuroectodermal tumors
08/26/2010US20100215575 Systemic Administration of Chlorotoxin Agents for the Diagnosis and Treatment of Tumors
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010US20100212667 Drug capsules for dry powder inhalers
08/26/2010CA2789515A1 Treatment of chronic inflammatory conditions
08/26/2010CA2754350A1 Oxyntomodulin analogs
08/26/2010CA2753294A1 Proproteins and methods of use thereof
08/26/2010CA2753181A1 Target-activated cell/tissue penetrating peptide for delivery of impermeable compounds and use thereof
08/26/2010CA2753170A1 Means for purifying a coagulation protein, and methods for implementing same
08/26/2010CA2753121A1 Compositions and methods to prevent and/or treat cancer with pa-card
08/26/2010CA2753101A1 Modified non-cytotoxic proteases
08/26/2010CA2753099A1 Modifications of cupredoxin derived peptides and methods of use thereof
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2752608A1 Cytotoxic conjugates having neuropeptide y receptor binding compound
08/26/2010CA2752560A1 Foxm1 peptides and vaccines containing the same
08/26/2010CA2752349A1 Aqueous transfer buffer
08/26/2010CA2751673A1 Analogues of neuropeptide y having proline substitution at position 34
08/26/2010CA2751636A1 Analogues of neuropeptide y having at least one synthetic amino acid substitution
08/26/2010CA2751311A1 Means and methods for manufacturing highly pure neurotoxin
08/26/2010CA2751032A1 Use of g-csf for the extension of the therapeutic time-window of thrombolytic stroke therapy
08/26/2010CA2745657A1 Extended length botulinum toxin formulation for human or mammalian use
08/26/2010CA2739905A1 Mimotopes of hiv env
08/25/2010EP2221376A2 Antisense modulation of superoxide dismutase 1, soluble expression
08/25/2010EP2221314A1 A soluble tumor necrosis factor receptor mutant
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP2221065A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
08/25/2010EP2221061A1 Antimicrobial peptides derived from CAP18
08/25/2010EP2221060A1 Use of specific peptides in the preparation of a medicament for the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS) or of Smoldering Multiple Myeloma (SMM)
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220108A2 Protein purification and endotoxin removal
08/25/2010EP2219679A1 Cross-linked hydrogel containing an active substance
08/25/2010EP2219666A1 Prostatic acid phosphatase for the treatment of pain
08/25/2010EP2219665A1 Parathyroid hormone formulations and uses thereof
08/25/2010EP2219664A1 Methods for treating obesity and obesity related diseases and disorders
08/25/2010EP2219663A1 Reverse protein
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 3163